Literature DB >> 16406263

17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.

Kiyoshi Ito1, Hiroki Utsunomiya, Takashi Suzuki, Sumika Saitou, Jun-Ichi Akahira, Kunihiro Okamura, Nobuo Yaegashi, Hironobu Sasano.   

Abstract

In situ estrogen metabolism and synthesis have been considered to play a very important role in the development and progression of human endometrial carcinoma. 17Beta-hydroxysteroid dehydrogenases (17-HSDs) are enzymes involved in the formation of active sex steroids, including testosterone, estrone (E1) and estradiol (E2). Estrogens are interchanged by two enzymes, 17-HSD types 1 and 2, type 1 converts E1 to E2, and type 2 does reverse actions. 17-HSD type 5 catalyzes the reduction of androstenedione to testosterone. 17-HSD type 2 expression was decreased through normal endometrium, hyperplasia and carcinoma accordingly. There was a significant inverse correlation between intratumoral E2 concentration and the level of 17-HSD type 2 mRNA in endometrial carcinoma. 17-HSD type 5 expression was significantly increased through normal endometrium, hyperplasia and carcinoma accordingly. These results indicated that 17-HSD types 2 and 5 play an important role in the regulation of in situ estrogen production in endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406263     DOI: 10.1016/j.mce.2005.11.038

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  16 in total

1.  Disruption of estrogen homeostasis as a mechanism for uterine toxicity in Wistar Han rats treated with tetrabromobisphenol A.

Authors:  J Michael Sanders; Sherry J Coulter; Gabriel A Knudsen; June K Dunnick; Grace E Kissling; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-15       Impact factor: 4.219

2.  Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.

Authors:  Aubrey L Park; Hsueh-Kung Lin; Qing Yang; Chor Wing Sing; Michael Fan; Timothy B Mapstone; Naina L Gross; Mary K Gumerlock; Michael D Martin; Craig H Rabb; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2010-03-25

3.  Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cells.

Authors:  Elif Keleş; Margarita Lianeri; Paweł Piotr Jagodziński
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

4.  Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Authors:  Carmen Visus; Diasuke Ito; Rajiv Dhir; Miroslaw J Szczepanski; Yoo Jung Chang; Jean J Latimer; Stephen G Grant; Albert B DeLeo
Journal:  Cancer Immunol Immunother       Date:  2011-03-16       Impact factor: 6.968

5.  Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.

Authors:  Valerie L Miller; Hsueh-Kung Lin; Paari Murugan; Michael Fan; Trevor M Penning; Lacy S Brame; Qing Yang; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2012-04-26

6.  The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Authors:  Paul A Foster; L W Lawrence Woo; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 7.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

8.  Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

Authors:  Taija Saloniemi; Päivi Järvensivu; Pasi Koskimies; Heli Jokela; Tarja Lamminen; Sadaf Ghaem-Maghami; Roberto Dina; Pauliina Damdimopoulou; Sari Mäkelä; Antti Perheentupa; Harry Kujari; Jan Brosens; Matti Poutanen
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

9.  Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.

Authors:  Theodore S Chang; Hsueh-Kung Lin; Kyle A Rogers; Lacy S Brame; Matthew M Yeh; Qing Yang; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

Review 10.  Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.

Authors:  Tea Lanišnik Rižner; Trevor M Penning
Journal:  Steroids       Date:  2013-11-01       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.